301 related articles for article (PubMed ID: 3491149)
1. Therapy of rat autoimmune disease by a monoclonal antibody specific for T lymphoblasts.
Schluesener H; Brunner C; Vass K; Lassmann H
J Immunol; 1986 Dec; 137(12):3814-20. PubMed ID: 3491149
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex.
Aharoni R; Teitelbaum D; Arnon R; Puri J
Nature; 1991 May; 351(6322):147-50. PubMed ID: 1709449
[TBL] [Abstract][Full Text] [Related]
3. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody.
Waldor MK; Mitchell D; Kipps TJ; Herzenberg LA; Steinman L
J Immunol; 1987 Dec; 139(11):3660-4. PubMed ID: 3500226
[TBL] [Abstract][Full Text] [Related]
4. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
[TBL] [Abstract][Full Text] [Related]
5. T lymphocyte clones and experimental autoimmune diseases.
Cohen IR
Behring Inst Mitt; 1985 Aug; (77):88-92. PubMed ID: 2417586
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion.
Achiron A; Margalit R; Hershkoviz R; Markovits D; Reshef T; Melamed E; Cohen IR; Lider O
J Clin Invest; 1994 Feb; 93(2):600-5. PubMed ID: 8113397
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.
Archelos JJ; Jung S; Mäurer M; Schmied M; Lassmann H; Tamatani T; Miyasaka M; Toyka KV; Hartung HP
Ann Neurol; 1993 Aug; 34(2):145-54. PubMed ID: 7687838
[TBL] [Abstract][Full Text] [Related]
8. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
Matsumoto Y; Tsuchida M; Hanawa H; Abo T
Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
[TBL] [Abstract][Full Text] [Related]
9. Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease.
Holmdahl R; Goldschmidt TJ; Kleinau S; Kvick C; Jonsson R
Immunology; 1992 Jun; 76(2):197-202. PubMed ID: 1634244
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune effector cells. V.A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis.
Swanborg RH
J Immunol; 1983 Apr; 130(4):1503-5. PubMed ID: 6187808
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.
Stepaniak JA; Gould KE; Sun D; Swanborg RH
J Immunol; 1995 Sep; 155(5):2762-9. PubMed ID: 7544385
[TBL] [Abstract][Full Text] [Related]
12. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
13. Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the alpha/beta T cell receptor.
Yoshino S; Schlipköter E; Kinne R; Hünig T; Emmrich F
Eur J Immunol; 1990 Dec; 20(12):2805-8. PubMed ID: 1702729
[TBL] [Abstract][Full Text] [Related]
14. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells.
Brostoff SW; Mason DW
J Immunol; 1984 Oct; 133(4):1938-42. PubMed ID: 6236260
[TBL] [Abstract][Full Text] [Related]
15. Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes.
Jyothi MD; Flavell RA; Geiger TL
Nat Biotechnol; 2002 Dec; 20(12):1215-20. PubMed ID: 12426577
[TBL] [Abstract][Full Text] [Related]
16. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
Beyersdorf N; Gaupp S; Balbach K; Schmidt J; Toyka KV; Lin CH; Hanke T; Hünig T; Kerkau T; Gold R
J Exp Med; 2005 Aug; 202(3):445-55. PubMed ID: 16061730
[TBL] [Abstract][Full Text] [Related]
17. Immunospecific drug design--prospects for treatment of autoimmune diseases.
Arnon R; Teitelbaum D
Ther Immunol; 1994 Jan; 1(1):65-70. PubMed ID: 7584481
[TBL] [Abstract][Full Text] [Related]
18. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.
Schluesener HJ; Sobel RA; Linington C; Weiner HL
J Immunol; 1987 Dec; 139(12):4016-21. PubMed ID: 3500978
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity.
Smeltz RB; Wolf NA; Swanborg RH
J Immunol; 1999 Aug; 163(3):1390-7. PubMed ID: 10415039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
